MedPath

Sexual Dysfunction in Women With Multiple Sclerosis (MS)

Recruiting
Conditions
Multiple Sclerosis
Multiple Sclerosis (MS) - Relapsing-remitting
Fatigue in Multiple Sclerosis
Sexual Disfunction
Cognitive Dysfunction
Depression
Anxiety
Overactive Bladder
Fatigue
Registration Number
NCT07193823
Lead Sponsor
Ege University
Brief Summary

Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction.

For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
140
Inclusion Criteria
  • Female patients aged 25-50 years
  • Literate and able to comprehend written and spoken instructions
  • Diagnosed with relapsing-remitting form of multiple sclerosis
  • Having a continuous/regular sexual partner
  • Expanded Disability Status Scale (EDSS) score ≤ 5
  • At least 3 months since the last relapse
  • Sexually active within the past 3 months
  • Spasticity level < grade 2 according to the Modified Ashworth Scale
Exclusion Criteria
  • Pregnancy
  • Illiteracy or inability to understand spoken or written instructions
  • Absence of a continuous/regular sexual partner
  • Expanded Disability Status Scale (EDSS) score > 5
  • Not sexually active within the past 3 months
  • Spasticity level ≥ grade 2 according to the Modified Ashworth Scale

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of sexual dysfunction in female patients with multiple sclerosisAt enrollment (Baseline, cross-sectional assessment)
Secondary Outcome Measures
NameTimeMethod
Association between sexual dysfunction and cognitive dysfunction, fatigue, depression, anxiety, and overactive bladder symptomsAt enrollment (Baseline, cross-sectional assessment)

Trial Locations

Locations (1)

Ege University Faculty of Medicine, Department of Neurology

Izmir, Bornova, Turkey (Türkiye)

Ege University Faculty of Medicine, Department of Neurology
Izmir, Bornova, Turkey (Türkiye)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.